Skip to main content

Advertisement

Log in

Regulation of the epigenome through RNA modifications

  • Review
  • Published:
Chromosoma Aims and scope Submit manuscript

Abstract

Chemical modifications of nucleotides expand the complexity and functional properties of genomes and transcriptomes. A handful of modifications in DNA bases are part of the epigenome, wherein DNA methylation regulates chromatin structure, transcription, and co-transcriptional RNA processing. In contrast, more than 150 chemical modifications of RNA constitute the epitranscriptome. Ribonucleoside modifications comprise a diverse repertoire of chemical groups, including methylation, acetylation, deamination, isomerization, and oxidation. Such RNA modifications regulate all steps of RNA metabolism, including folding, processing, stability, transport, translation, and RNA’s intermolecular interactions. Initially thought to influence all aspects of the post-transcriptional regulation of gene expression exclusively, recent findings uncovered a crosstalk between the epitranscriptome and the epigenome. In other words, RNA modifications feedback to the epigenome to transcriptionally regulate gene expression. The epitranscriptome achieves this feat by directly or indirectly affecting chromatin structure and nuclear organization. This review highlights how chemical modifications in chromatin-associated RNAs (caRNAs) and messenger RNAs (mRNAs) encoding factors involved in transcription, chromatin structure, histone modifications, and nuclear organization affect gene expression transcriptionally.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Not applicable.

References

Download references

Acknowledgements

We thank Kevin Vasquez for insightful discussions.

Funding

This work was supported by the National Cancer Institute (NCI) grant R00CA245035, the American Association for Cancer Research (AACR) grant 22–20-01-ARAN, and a V Scholar Award V2022-016. E.A.P. was funded by the Austrian Marshall Plan Foundation.

Author information

Authors and Affiliations

Authors

Contributions

E.A.P., S.R., and D.A. wrote the first draft. E.A.P. and D.A. edited the final draft. D.A. prepared the figures.

Corresponding author

Correspondence to Daniel Arango.

Ethics declarations

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patrasso, E.A., Raikundalia, S. & Arango, D. Regulation of the epigenome through RNA modifications. Chromosoma 132, 231–246 (2023). https://doi.org/10.1007/s00412-023-00794-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00412-023-00794-7

Keywords

Navigation